Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

E-Poster Display

1579P - Burnout among oncology professionals in the Middle East and North Africa (MENA)

Date

17 Sep 2020

Session

E-Poster Display

Topics

Psychosocial Aspects of Cancer

Tumour Site

Presenters

Atlal Abusanad

Citation

Annals of Oncology (2020) 31 (suppl_4): S898-S902. 10.1016/annonc/annonc286

Authors

A.M. Abusanad1, A. Bensalem2, E. Shash3, L.Y.I. Mula-Hussain4, Z. Benbrahim5, S. Khatib6, N. Abdelhafiz7, J. Ansari8, H. Jradi9, K. Alkattan10, A.R. Jazieh7

Author affiliations

  • 1 Faculty Of Medicine, Oncology Division, King Abdulaziz University, 21589 - Jeddah/SA
  • 2 Oncology Dept., CHU Dr Benbadis, 25000 - Constantine/DZ
  • 3 Medical Oncology, National Cancer Institute - Cairo University, 11796 - Cairo/EG
  • 4 Radiation Oncology Department, University of Ottawa, 000 - Ottawa/CA
  • 5 Medical Oncology, CHU - University Hospital of Hassan II, 30000 - Fez/MA
  • 6 Oncology Department, Private sector, 11942 - Amman/JO
  • 7 Oncology Dept., King Abdulaziz Medical City-Riyadh, 11426 - Riyadh/SA
  • 8 Medical Oncology, Tawam Hospital, 0000 - Al Ain/AE
  • 9 Public Health, King Saud bin Abdulaziz University for Health Sciences, 0000 - Riyadh/SA
  • 10 King Faisal Specialist Hospital & Research Centre., Alfaisal University,, 12713 - Riyadh/SA

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 1579P

Background

Burnout (BT) is a major challenge affecting healthcare professionals with negative impact on personal and organizational levels. Our study aimed to assess the prevalence of BT among oncology physicians (OP) in the MENA region and its predictors.

Methods

A cross-sectional study utilizing an online questionnaire of the validated Maslach Burnout Inventory (MBI) of emotional exhaustion (EE), Depersonalization (DE), and Personal Achievement (PA) plus questions regarding demography/work-related factors and attitudes toward oncology was distributed to (OP) across the Arab region. Data were analyzed to measure BT prevalence, severity and associated factors.

Results

Between February 10 and March 15, 2020, 1054 participants responded. Of the 1017 eligible participants, 64% were medical oncologists, 80% were <40 years, 54% females, 74% married, 67% with children, and 40% practiced hobby. BT prevalence is 68%. High EE and DE reported in 35%, and 57%, respectively, while 49% scored low PA. High BT is associated with younger age (P<0.001), administrative work >25%/day (P=0.003), and quitting oncology thought (P<0.001) (Table). Whereas practicing hobby (P=0.02), enjoying oncology communications (P<0.001), and appreciating oncology life-work balance (P=0.021) are associated with reduced BT score and prevalence. NA countries reported the highest BT prevalence (P<0.001). Gender, marital status, children, subspecialty, years in practice, and practicing setting/number impacted neither BT prevalence nor its severity. Seventy-two percent lacked BT education/support. Table: 1579P

The thought of quitting oncology is consistently predictive of high EE, DE and Low PA

Thought of quitting oncology High EE Adjusted OR (95%CI) P-value High DE Adjusted OR (95%CI) P-value Low PA Adjusted OR (95%CI) P-value
Always 6.9 (4.00-12.22) <0.001 7.85 (4.05-15.24) <0.001 3.14 (1.81-5.48) <0.001
Sometimes 4.47 (3.07-6.50) <0.001 3.67 (2.61-5.16) <0.001 2.14 (1.45-3.15) <0.001
Rarely 1.58 (1.02-2.44) 0.038 1.65 (1.14-2.38) 0.007 1.93 (1.25- 2.98) 0.003
Never (ref) 1 1 1

Conclusions

BT among OP in the MENA region is alarmingly prevalent. The thought of quitting oncology is a consistent predictor for high BT and sub-domains, which makes it a potential screening tool to detect BT. Proactive interventions to mitigate and manage burnout are urgently needed which, in turn, should reflect positively on patients’ care.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

The authors.

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.